1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTER ENDED JUNE 30, 2001 Commission File No.: 001-8833 HEALTHSTREAM, INC. (Exact name of registrant as specified in its charter) TENNESSEE 62-1443555 --------- ---------- (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 209 10TH AVENUE SOUTH, SUITE 450 NASHVILLE, TENNESSEE 37203 -------------------- ----- (Address of principal executive offices) (Zip Code) (615) 301-3100 -------------- (Registrant's telephone number, including area code) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] As of August 10, 2001, 20,366,057 shares of the Registrant's common stock were outstanding.
2 INDEX TO FORM 10-Q HEALTHSTREAM, INC. <TABLE> <CAPTION> PAGE NUMBER ------ <S> <C> Part I. Financial Information Item 1. Financial Statements Condensed Consolidated Balance Sheets - December 31, 2000 and June 30, 2001 (Unaudited)................................................. 1 Condensed Consolidated Statements of Operations (Unaudited) - Three Months Ended June 30, 2000 and 2001.............................................. 2 Condensed Consolidated Statements of Operations (Unaudited) - Six Months Ended June 30, 2000 and 2001.............................................. 3 Condensed Consolidated Statement of Shareholders' Equity (Unaudited)...... 4 Condensed Consolidated Statements of Cash Flows (Unaudited) - Six Months Ended June 30, 2000 and 2001.............................................. 5 Notes to Condensed Consolidated Financial Statements...................... 7 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations............................................................. 11 Item 3. Quantitative and Qualitative Disclosures About Market Risk................ 18 Part II. Other Information Item 1. Legal Proceedings......................................................... 19 Item 2. Changes in Securities and Use of Proceeds................................. 19 Item 4. Submission of Matters to a Vote of Security Holders....................... 19 Item 6. Exhibits and Reports on Form 8-K.......................................... 20 Signature................................................................. 21 </TABLE>
3 PART I. FINANCIAL INFORMATION ITEM 1. Financial Statements HEALTHSTREAM, INC. CONDENSED CONSOLIDATED BALANCE SHEETS <TABLE> <CAPTION> DECEMBER 31, JUNE 30, 2000 2001 ------------ ------------ (NOTE 1) (UNAUDITED) <S> <C> <C> ASSETS Current Assets: Cash and cash equivalents ................................................. $ 19,830,572 $ 9,214,680 Short term investments .................................................... 7,451,450 18,432,361 Restricted cash ........................................................... 794,342 392,430 Interest receivable ....................................................... 578,534 525,803 Accounts receivable, net of allowance for doubtful accounts of $198,000 in 2000 and $185,000 in 2001 .............................. 3,957,149 4,056,797 Accounts receivable - unbilled ............................................ 49,600 339,245 Prepaid development fees .................................................. 695,427 1,143,805 Notes receivable, current portion ......................................... 221,750 221,750 Other prepaid expenses and other current assets ........................... 1,075,776 1,251,555 ------------ ------------ Total current assets ................................................... 34,654,600 35,578,426 Property and equipment: Furniture and fixtures .................................................... 883,660 913,188 Construction in progress .................................................. 117,000 -- Equipment ................................................................. 3,893,720 4,485,180 Leasehold improvements .................................................... 885,630 954,183 ------------ ------------ 5,780,010 6,352,551 Less accumulated depreciation and amortization ............................ (1,505,004) (2,256,433) ------------ ------------ 4,275,006 4,096,118 Intangible assets, net of accumulated amortization of $5,847,000 in 2000 and $9,600,000 in 2001 .............................. 18,024,526 15,397,841 Investments .................................................................. 12,889,674 2,680,248 Note receivable, net of current portion ...................................... -- 215,000 Other assets ................................................................. 607,770 482,512 ------------ ------------ Total assets ........................................................ $ 70,451,576 $ 58,450,145 ============ ============ LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable .......................................................... $ 1,150,996 $ 1,056,476 Accrued liabilities ....................................................... 1,719,906 1,821,014 Accrued royalties ......................................................... 1,500,000 90,110 Registration liabilities .................................................. 794,342 392,430 Deferred revenue .......................................................... 2,764,235 2,639,739 Current portion of capital lease obligations .............................. 288,831 174,074 ------------ ------------ Total current liabilities ........................................... 8,218,310 6,173,843 Capital lease obligations, less current portion .............................. 216,072 140,788 Commitments and contingencies Shareholders' equity: Common stock, no par value, 75,000,000 shares authorized; 21,242,312 shares and 20,366,057 shares issued and outstanding at December 31, 2000 and June 30, 2001, respectively ................... 91,221,775 90,715,647 Accumulated other comprehensive income .................................... 30,556 244,295 Accumulated deficit ....................................................... (29,235,137) (38,824,428) ------------ ------------ Total shareholders' equity .......................................... 62,017,194 52,135,514 ------------ ------------ Total liabilities and shareholders' equity .......................... $ 70,451,576 $ 58,450,145 ============ ============ </TABLE> See accompanying notes. 1
4 HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) <TABLE> <CAPTION> THREE MONTHS ENDED JUNE 30, 2000 2001 ------------ ------------ <S> <C> <C> Revenues, net of warrant expense of $330,095 and $504,803 in 2000 and 2001 ..................................... $ 2,200,759 $ 3,523,348 Operating costs and expenses: Cost of revenues ..................................... 1,039,726 1,112,227 Product development .................................. 1,238,562 1,284,341 Office consolidation charge .......................... -- 400,678 Selling, general and administrative expenses ......... 5,930,369 6,309,868 ------------ ------------ Total operating costs and expenses ............. 8,208,657 9,107,114 ------------ ------------ Loss from operations .................................... (6,007,898) (5,583,766) ------------ ------------ Other income (expense): Interest and other income ............................ 486,894 388,812 Interest expense - related parties ................... (6,970) -- Interest expense ..................................... (28,440) (12,758) ------------ ------------ 451,484 376,054 ------------ ------------ Net loss ................................................ $ (5,556,414) $ (5,207,712) ============ ============ Net loss per share: Basic ................................................ $ (0.30) $ (0.26) ============ ============ Diluted .............................................. $ (0.30) $ (0.26) ============ ============ Weighted average shares of common stock outstanding: Basic ................................................ 18,595,372 19,654,707 ============ ============ Diluted .............................................. 18,595,372 19,654,707 ============ ============ </TABLE> See accompanying notes. 2
5 HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) <TABLE> <CAPTION> SIX MONTHS ENDED JUNE 30, 2000 2001 ------------ ------------ <S> <C> <C> Revenues, net of warrant expense of $330,095 and $940,855 in 2000 and 2001 ..................................... $ 3,645,701 $ 6,577,310 Operating costs and expenses: Cost of revenues ..................................... 1,797,786 2,617,483 Product development .................................. 2,428,632 2,487,559 Office consolidation charge .......................... -- 400,678 Selling, general and administrative expenses ......... 9,109,810 11,621,773 ------------ ------------ Total operating costs and expenses ............. 13,336,228 17,127,493 ------------ ------------ Loss from operations .................................... (9,690,527) (10,550,183) ------------ ------------ Other income (expense): Interest and other income ............................ 730,044 1,087,683 Write off of investment .............................. -- (99,920) Interest expense - related parties ................... (34,255) -- Interest expense ..................................... (65,849) (26,871) ------------ ------------ 629,940 960,892 ------------ ------------ Net loss ................................................ $ (9,060,587) $ (9,589,291) ============ ============ Net loss per share: Basic ................................................ $ (0.78) $ (0.48) ============ ============ Diluted .............................................. $ (0.78) $ (0.48) ============ ============ Weighted average shares of common stock outstanding: Basic ................................................ 11,669,264 19,811,171 ============ ============ Diluted .............................................. 11,669,264 19,811,171 ============ ============ </TABLE> See accompanying notes. 3
6 HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (UNAUDITED) <TABLE> <CAPTION> ACCUMULATED OTHER TOTAL COMMON STOCK ACCUMULATED COMPREHENSIVE SHAREHOLDERS SHARES AMOUNT DEFICIT INCOME EQUITY ----------- ------------ ------------ -------- ------------ <S> <C> <C> <C> <C> <C> Balance at December 31, 2000 ............... 21,242,312 $ 91,221,775 $(29,235,137) $ 30,556 $ 62,017,194 ----------- ------------ ------------ -------- ------------ Net loss ................................... -- -- (9,589,291) -- (9,589,291) Unrealized gain on investment, net of reclassification adjustment and tax .. -- -- -- 213,739 213,739 -------- ------------ Comprehensive loss ......................... -- -- -- -- (9,375,552) ------------ Issuance of common stock in acquisitions ... 181,250 300,186 -- -- 300,186 Issuance of common stock to Employee Stock Purchase Plan ........................... 53,606 56,956 -- -- 56,956 Repurchase of shares in connection with WebMD renegotiation .................. (1,111,111) (1,981,444) -- -- (1,981,444) Valuation of WebMD repurchase right ........ -- 120,000 -- -- 120,000 Issuance of stock options to advisory boards -- 57,319 -- -- 57,319 Recognition of warrant expense ............. -- 940,855 -- -- 940,855 ----------- ------------ ------------ -------- ------------ Balance at June 30, 2001 ................... 20,366,057 $ 90,715,647 $(38,824,428) $244,295 $ 52,135,514 =========== ============ ============ ======== ============ </TABLE> 4
7 HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) <TABLE> <CAPTION> SIX MONTHS ENDED JUNE 30, 2000 2001 ------------ ------------ <S> <C> <C> OPERATING ACTIVITIES: Net loss ............................................................ $ (9,060,587) $ (9,589,291) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation .................................................. 309,171 805,162 Amortization .................................................. 2,266,863 3,753,000 Gain on WebMD renegotiation ................................... -- (1,500,000) Office consolidation charge ................................... -- 400,678 Noncash warrant expense ....................................... 330,095 940,855 Amortization of content fees .................................. -- 216,237 Amortization of fixed royalties ............................... -- 127,692 Noncash compensation expense .................................. 45,900 35,250 Issuance of stock options to advisory boards .................. -- 57,319 Loss on write off of investment ............................... -- 99,920 Gain on sale of investment .................................... (94,438) -- Changes in operating assets and liabilities, excluding effects of acquisitions: Restricted cash ............................................ -- 401,912 Interest receivable ........................................ -- 52,731 Accounts receivable ........................................ (822,358) (189,472) Accounts receivable - unbilled ............................. (326,609) (289,645) Prepaid development fees ................................... -- (664,615) Other prepaid expenses and other current assets ............ (786,243) (678,639) Other assets ............................................... 131,733 (304,742) Accounts payable ........................................... 387,753 (94,520) Accrued royalties and other liabilities .................... 240,187 (220,120) Registration liabilities ................................... -- (401,912) Deferred revenue ........................................... (427,501) (282,153) ------------ ------------ Net cash used in operating activities .................... (7,806,034) (7,324,353) INVESTING ACTIVITIES: Acquisition of companies, net of cash acquired ...................... (1,481,807) (328,988) Proceeds from sale of investment .................................... 122,271 -- Issuance of note receivable ......................................... -- (215,000) Purchase of property and equipment .................................. (1,318,360) (633,022) ------------ ------------ Net cash used in investing activities .................... (2,677,896) (1,177,010) </TABLE> 5
8 HEALTHSTREAM, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED), CONTINUED <TABLE> <CAPTION> SIX MONTHS ENDED JUNE 30, 2000 2001 ------------ ------------ <S> <C> <C> FINANCING ACTIVITIES: Repurchase of common stock from WebMD ............................... -- (1,981,444) Proceeds from issuance of common stock, net of underwriting discount 54,151,750 -- Expenses of issuing common stock .................................... (1,977,629) -- Repayment of note payable ........................................... (1,180,000) -- Issuance of common stock to Employee Stock Purchase Plan ............ -- 56,956 Proceeds from exercise of stock options ............................. 356,866 -- Payments on notes payable - related party ........................... (82,559) -- Repurchase of common stock in connection with initial public offering (14,213) -- Payment on notes payable ............................................ (50,000) -- Payments on capital lease obligations ............................... (95,826) (190,041) ------------ ------------ Net cash provided by (used in) financing activities ...... 51,108,389 (2,114,529) ------------ ------------ Net increase (decrease) in cash and cash equivalents ................ 40,624,459 (10,615,892) Cash and cash equivalents at beginning of period .................... 13,632,144 19,830,572 ------------ ------------ Cash and cash equivalents at end of period .......................... $ 54,256,603 $ 9,214,680 ============ ============ Total cash, restricted cash, investments and accrued interest at end of period ................................................. $ 54,256,603 $ 31,245,522 ============ ============ SUPPLEMENTAL CASH FLOW INFORMATION: Interest paid ....................................................... $ 95,576 $ 14,113 ============ ============ Capital lease obligations incurred .................................. $ 325,050 $ -- ============ ============ Preferred stock converted into common stock ......................... $ 19,172,060 $ -- ============ ============ Notes payable - related parties converted into common stock ......... $ 1,293,000 $ -- ============ ============ Effects of acquisitions: Estimated fair value of assets acquired .................... $ 1,196,740 $ 5,000 Purchase price in excess of net assets acquired ............ 13,920,389 1,036,491 Estimated fair value of liabilities assumed ................ (3,427,806) (412,317) Stock issued ............................................... (10,090,200) (300,186) ------------ ------------ Cash paid .................................................. 1,599,123 328,988 Less cash acquired ......................................... (117,316) -- ------------ ------------ Net cash paid for acquisitions ............................. $ 1,481,807 $ 328,988 ============ ============ </TABLE> See accompanying notes. 6
9 HEALTHSTREAM, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. All significant inter-company transactions have been eliminated in consolidation. Operating results for the three and six months ended June 30, 2001 are not necessarily indicative of the results that may be expected for the year ending December 31, 2001. The balance sheet at December 31, 2000 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. For further information, refer to the financial statements and footnotes thereto for the year ended December 31, 2000 (included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission). During the second quarter of 2000, the Company began recognizing revenues under a services agreement with HCA Information Technology & Services, Inc. formerly known as Columbia Information Systems, an affiliate of HCA Inc. formerly known as HCA - The Healthcare Company (collectively referred to herein as "HCA"). The Company granted HCA a warrant to purchase HealthStream, Inc. common stock. The accompanying Condensed Consolidated Statements of Operations reflect revenues related to the services provided, net of the amortization of the fair value of the related warrant as a reduction of the revenues proportionately over the term of the four-year agreement. The amortization will fluctuate based on the revenues received from this agreement and will vary as a percentage of revenues based on the estimated revenues over the course of the agreement. 2. MERGERS AND ACQUISITIONS m3 the Healthcare Learning Company. On January 28, 2000, the Company acquired substantially all of the assets and liabilities of Multimedia Marketing, Inc. d/b/a m3 the Healthcare Learning Company ("m3") for $0.6 million in cash and 818,037 shares of the Company's common stock. m3 provided interactive, multimedia education and training solutions to hospitals and other healthcare organizations. A portion of the shares was held in an escrow account for one year, subject to claims for indemnification pursuant to the agreement and plan of merger. In connection with the acquisition, the Company assumed $1.2 million of long-term debt, which was repaid with the proceeds of the Company's initial public offering. The acquisition was accounted for as a purchase. Intangible assets acquired consisted of goodwill and customer lists of $8.4 million and $1.0 million, respectively, and are being amortized on a straight-line basis over three years. EMINet, Inc. On January 28, 2000, the Company acquired substantially all of the assets of Emergency Medicine Internetwork, Inc. d/b/a EMINet ("EMINet") for $0.6 million in cash and 269,902 shares of the Company's common stock. A portion of the shares are held in escrow, subject to claims for indemnification pursuant to the asset purchase agreement. In addition, the Company issued 2,170 additional shares of common stock based on achievement of revenue goals subsequent to the acquisition. EMINet sold approved online medical education content to emergency medical services personnel. The acquisition was accounted for as a purchase. Intangible assets acquired consisted of goodwill and customer lists of $2.8 million and $0.5 million, respectively, and are being amortized on a straight-line basis over three years. 7
10 HEALTHSTREAM, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) Education Design, Inc. On July 1, 2000, the Company acquired substantially all of the assets of Education Design, Inc. ("EDI") for $3.0 million in cash and 184,421 shares of the Company's common stock. Three-quarters of the shares were held in an escrow account for one year, subject to any claims for indemnification pursuant to the asset purchase agreement. In addition, approximately $300,000 of cash and 31,711 shares of the Company's common stock were provided to the employees of EDI, subject to certain restricted stock award agreements. EDI provided services for live educational events that are supported by the medical device industry. The acquisition was accounted for as a purchase. Intangible assets acquired consisted of goodwill, content, customer lists, and a non-competition agreement of $1.9 million, $1.5 million, $0.3 million, and $0.1 million, respectively, and are being amortized on a straight-line basis over five years, five years, three years and one year, respectively. SynQuest Technologies, Inc. On September 18, 2000, the Company acquired substantially all of the assets of SynQuest Technologies, Inc. ("SynQuest") for 787,087 shares of the Company's common stock and assumption of certain debt and other liabilities, $2.3 million of which were repaid in connection with the purchase transaction. Approximately two-thirds of the shares will be held in an escrow account subject to any claims or are subject to certain stock vesting agreements. SynQuest provided online training and education to hospitals and healthcare organizations. The acquisition was accounted for as a purchase. Intangible assets acquired consisted of goodwill, content, and customer lists of $2.1 million, $2.0 million, $0.5 million, respectively, and are being amortized on a straight-line basis over five years, three years, and three years, respectively. The allocation of purchase price is preliminary and may be subject to change as a result of changes in estimates related to the acquired business. de'MEDICI Systems. On January 26, 2001, the Company acquired substantially all of the assets of de'MEDICI Systems ("de'MEDICI"), a business unit of Lippincott Williams & Wilkins, Inc., for approximately $360,000 in cash and 181,250 shares of the Company's common stock. de'MEDICI provided computer based education and training to over 230 hospitals and healthcare organizations. The acquisition was accounted for as a purchase. Intangible assets acquired consisted of goodwill, customer lists and trade name of $0.6 million, $0.3 million and $0.1 million, respectively, and are being amortized on a straight-line basis over five years, three years, and three years, respectively. The allocation of purchase price is preliminary and may be subject to change as a result of changes in estimates related to the acquired business. The following unaudited pro forma results of operations give effect to the operations of the acquired companies as if the respective acquisitions had occurred on the first day of 2000. The pro forma results of operations do not purport to represent what the Company's results of operations would have been had such transactions in fact occurred at the beginning of the period presented or to project the Company's results of operations in any future period. <TABLE> <CAPTION> SIX MONTHS ENDED JUNE 30, 2000 ------------- <S> <C> Revenues............................................... $ 7,156,000 Net loss............................................... $ (11,372,000) Net loss per share: Basic............................................. $ (0.92) Diluted........................................... $ (0.92) </TABLE> Since the pro forma impact of the de'MEDICI acquisition is not material to the results presented for 2001, no pro forma disclosures are presented. In accordance with SFAS 128, escrowed shares and any shares subject to restrictions or vesting are excluded from the weighted average shares outstanding for purposes of calculating net loss per share since such shares are anti-dilutive. 8
11 HEALTHSTREAM, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) 3. NET LOSS PER SHARE Basic net loss per share is computed by dividing the net loss available to common shareholders for the period by the weighted-average number of common shares outstanding during the period. Diluted loss per share is computed by dividing the net loss for the period by the weighted average number of common and dilutive potential common shares outstanding during the period. Potential common shares, composed of incremental common shares issuable upon the exercise of stock options and warrants, escrowed or restricted shares, and common shares issuable on assumed conversion of series A, B, and C convertible preferred stock (prior to the IPO), are included in diluted net loss per share only when these shares are dilutive. The total number of shares excluded from the calculations of dilutive loss per share was approximately 5,600,000 at June 30, 2000 and approximately 5,800,000 at June 30, 2001. 4. INITIAL PUBLIC OFFERING On April 14, 2000, the Company completed its initial public offering ("IPO") of 5,275,000 shares of its common stock for net proceeds of $42.2 million. On April 14, 2000, the Company completed a private placement of 1,111,111 shares of its common stock to WebMD, formerly Healtheon/WebMD Corporation ("WebMD"), for net proceeds of $10.0 million. Upon consummation of the IPO, all series A, B, and C convertible preferred stock converted by its terms into 7,131,153 shares of our common stock. In addition, a $1,293,000 promissory note payable to Robert A. Frist, Jr., the Company's chief executive officer and chairman, also converted into 553,711 shares of common stock. Prior to the IPO, the Company effected a 1.85 for one common stock split. All share and per share information has been restated to reflect the stock split. During May 2000, the Company repaid the long-term note payable assumed in connection with the acquisition of m3 using a portion of the proceeds of the IPO. 5. RELATIONSHIP WITH WEBMD In February 2000, we entered into an agreement with WebMD which provided for us to be the exclusive provider of education, continuing education and training services for healthcare organizations, healthcare professionals and healthcare workers on Web sites owned or operated by WebMD. The agreement provided for payments to WebMD of $6.0 million per year for five years on a quarterly basis as guaranteed minimum royalties. In the first year, $2.0 million of the $6.0 million payment was to be applied toward mutually agreed upon branding and promotion services. Under the agreement, we were to receive 100% of any revenues from the sale of our products and services until we recovered all payments to WebMD, after which we would receive 75% and WebMD would receive 25% of any revenues. On January 5, 2001, the Company terminated its prior agreement with WebMD and entered into a new business arrangement. Under the new, non-exclusive three-year agreement, the Company is a preferred provider of continuing medical education, continuing education and board preparation courses for WebMD's professional portal. Under this new arrangement, financial consideration is based entirely on revenues generated from the sale of HealthStream's services to WebMD's professional portal customers. The arrangement also terminated the lock-up agreement related to 1.1 million shares of HealthStream common stock that WebMD purchased in a private offering just prior to the Company's IPO. In connection with this termination, HealthStream gave WebMD the right to sell the shares back to HealthStream at any time through March 30, 2001. On February 8, 2001, WebMD exercised its right to sell the 1.1 million shares of HealthStream common stock back to the Company at $1.7833 per share. The Company reacquired the shares on February 16, 2001. In connection with the termination of the prior WebMD agreement, HealthStream recognized a gain of $1.5 million, representing the reversal of the scheduled $1.5 million fixed payment that was accrued during the quarter ended September 30, 2000. 9
12 HEALTHSTREAM, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) 6. OFFICE CONSOLIDATION CHARGE During the quarter ended June 30, 2001, the Company recorded a non recurring office consolidation charge of $400,678 as a result of closure of its Dallas and Boston offices. The charge consisted of lease obligations of approximately $245,000 and impairment of certain fixed assets of approximately $155,000. 7. RECENT ACCOUNTING PRONOUNCEMENTS In June 2001, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 141, Business Combinations, and No. 142, Goodwill and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. Under the new rules, goodwill and intangible assets deemed to have indefinite lives will no longer be amortized but will be subject to annual impairment tests in accordance with the Statements. Other intangible assets will continue to be amortized over their useful lives. The Company will apply the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of 2002. While the Company has not completed its assessment of the impact of these Statements, application of the non amortization provisions of the Statement would result in an decrease in net loss of approximately $7.5 million, ($0.38 per share) per year. This estimate is based on the Company's current level of amortization expense for all intangibles and the current weighted average shares outstanding. During 2002, the Company will perform the first of the required impairment tests of goodwill and indefinite lived intangible assets as of January 1, 2002. The Company has not yet determined what the effect of these tests will be on the earnings and financial position of the Company. 8. CONTINGENCIES On November 17, 2000, a complaint was filed by Challenger Corporation in the Circuit Court of Tennessee for the Thirtieth Judicial District at Memphis against HealthStream, SynQuest Technologies, Inc. and two individual shareholders of SynQuest Technologies. The complaint asserts that HealthStream violated the terms of a licensing agreement entered into between HealthStream and the plaintiff and that HealthStream allegedly failed to pay royalties due to the plaintiff pursuant to the terms of that agreement. The plaintiff also alleges that HealthStream induced SynQuest Technologies to breach a marketing agreement allegedly entered into between SynQuest and the plaintiff. Alternatively, the plaintiff alleges that HealthStream, which purchased certain assets of SynQuest, is liable for SynQuest's alleged breach of the marketing agreement pursuant to the legal theory of successor liability. The aggregate damages alleged total approximately $9.0 million. We believe the allegations in the complaint are without merit, intend to defend the litigation vigorously and do not believe this litigation will have a material adverse effect on our financial condition or results of operations. 10
13 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS SPECIAL CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report includes various forward-looking statements that are subject to risks and uncertainties. Forward-looking statements include without limitation, statements preceded by, followed by, or that otherwise include the words "believes," "expects," "anticipates," "intends," "estimates" or similar expressions. For those statements, HealthStream, Inc. claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The following important factors, in addition to those discussed elsewhere in this Quarterly Report, could affect the future financial results of the Company and could cause actual results to differ materially from those expressed in forward-looking statements contained in this document: - our limited operating history; - variability and length of our sales cycle and our product mix; - our history of losses and expectations of continued losses; - our ability to manage rapid growth; - successful implementation of the Company's operating and growth strategy; - our ability to identify, complete and integrate the operations or realize the anticipated results of acquisitions; - fluctuations in quarterly operating results caused by a variety of factors including the timing of sales and development contracts as well as the adoption of the Internet as a tool for online training and continuing education in the healthcare industry; - successful establishment and maintenance of new and existing relationships with content partners; and - global and/or regional economic factors and potential changes in laws and regulations, including, without limitation, changes in federal, state and international laws regulating education, training and Internet transactions. For additional information concerning risks and uncertainties that may affect the Company's results of operations, please see the risks outlined under the heading "Risk Factors" in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission. OVERVIEW HealthStream was originally incorporated in 1990 and initiated online operations in March 1999. The Company has evolved from a multimedia content development service provider to a facilitator of computer based training capabilities targeted at the healthcare industry. Revenues are derived from the following categories: provision of services through our application service provider ("ASP") products, content subscriptions, licenses of installed learning management systems, maintenance and technical support services, content and courseware development, sponsorship services, sales of CD-ROM products, Web cast events, event development and registration services, Web site development, online products and training services. Our products and services are targeted at healthcare organizations and pharmaceutical and medical device companies. 11
14 ASP-based products and services, including content subscriptions, are provided on a monthly subscription fee basis based on the number of people within a facility and the content offerings. Revenue derived from our ASP-based products are recognized ratably over the term of the service agreement. The Company also offers training services for ASP users to facilitate integration of this technology. Fees for training are based on the time and efforts of the personnel involved. Revenue for transaction-based online course sales is recognized when the course is delivered. Revenues provided under a service agreement that included the grant of a warrant to HCA are recognized as services are rendered, net of the amortization of the fair value of the related warrant as a reduction of the revenues proportionately over the term of the four-year agreement. Revenue recognition policies for ASP-based products and services vary significantly from our installed products. Revenues from installed learning management system fees are recognized upon shipment or installation of the software. Revenues related to installed learning management systems may be subject to fluctuations because purchases of these licenses typically are included in customers' capital expenditure budgets. Charges for services such as training, maintenance and technical support are either based on a fixed fee, estimated usage or actual time incurred. Maintenance and technical support revenues are recognized over the term of the service period. Sponsorship revenue is recognized ratably over the term unless usage exceeds the ratable portion. Revenues derived from the sale of products requiring significant modification, conversion or customization are recorded based on the percentage of completion method using labor hours. Multimedia development revenues are recognized based on the percentage of a project that is completed, while revenues for live event development services are recognized based on the percentage of completion method using labor hours. Event registration services are recognized upon completion of the related event. All other service revenues are recognized as the related services are performed or products are delivered. Historically, we have marketed our training and education delivery system directly or licensed it to resellers to re-brand and distribute under their private label. Our primary reseller relationship was with Lippincott Williams & Wilkins, Inc. ("LWW"), a leading medical sciences publisher. LWW's business unit, de'MEDICI Systems, combined its line of training content mandated by the Occupational Safety and Hazards Administration ("OSHA") and the Joint Commission on the Accreditation of Healthcare Organizations ("JCAHO") with our installed learning management systems and their sales force sold the resulting solution directly into healthcare organizations. In January 2001, we purchased de'MEDICI Systems from LWW and acquired the existing base of more than 230 customers. We expect to continue to generate revenues by marketing our products and services to healthcare workers through healthcare organizations. We expect that the portion of our revenues related to our ASP-based products and services will increase. Specifically, we will seek to generate revenues from healthcare workers by marketing to their employers or sponsoring organizations. An integral part of the Company's strategy is to acquire companies that complement our products and services. Because of the financial impact of the Company's recent acquisitions, the period-to-period comparisons of our financial results are not necessarily meaningful. We have acquired the following companies since January 1, 2000: - m3 the Healthcare Learning Company, which provided computer-based training to over 450 hospitals and healthcare facilities, primarily in the areas of OSHA and JCAHO regulatory training, for $600,000 in cash, the assumption of $1.2 million in long-term debt and 818,036 shares of our common stock; - EMINet, which provided Web-based educational content for emergency medical services personnel, for $640,000 in cash and 272,072 shares of our common stock; - Education Design Inc., which provided services for live educational events that are supported by the medical device industry, for $3.0 million in cash and 184,421 shares of the Company's common stock. In addition, approximately $300,000 of cash and 31,711 shares of the Company's common stock were provided to the employees of EDI, subject to certain restricted stock award agreements. 12
15 - SynQuest Technologies, Inc., which provided online training and education to hospitals and healthcare organizations, for 787,087 shares of the Company's common stock and the assumption of certain debt and other liabilities, $2.3 million of which were repaid in connection with the purchase transaction. - de'MEDICI Systems, which provided computer based education and training to over 230 hospitals and healthcare organizations, for approximately $360,000 and 181,250 shares of the Company's common stock. In February 2000, we entered into a four-year agreement with HCA pursuant to which we provide online training and education, courseware development and administrative management and consulting services to HCA and its affiliated and managed healthcare providers. Under this agreement, the Company is billing a minimum of $12 million for the aforementioned services over the four year term, with the minimum in the first year approximating $2.0 million. In February 2000, we entered into an agreement with WebMD which provided for us to be the exclusive provider of education, continuing education and training services for healthcare organizations, healthcare professionals and healthcare workers on Web sites owned or operated by WebMD. The agreement provided for payments to WebMD of $6.0 million per year for five years on a quarterly basis as guaranteed minimum royalties. In the first year, $2.0 million of the $6.0 million payment was to be applied toward mutually agreed upon branding and promotion services. Under the agreement, we were to receive 100% of any revenues from the sale of our products and services until we recovered all payments to WebMD, after which we would receive 75% and WebMD would receive 25% of any revenues. WebMD purchased $10.0 million of our common stock at the initial public offering price in a private sale. On January 5, 2001, the Company terminated its prior agreement with WebMD and entered into a new business arrangement. Under the new, non-exclusive three-year agreement, the Company is a preferred provider of continuing medical education, continuing education and board preparation courses for WebMD's professional portal. Under this new arrangement, financial consideration is based entirely on revenues generated from the sale of HealthStream's services to WebMD's professional portal customers. The arrangement also terminated the lock-up agreement related to 1.1 million shares of HealthStream common stock that WebMD purchased in a private offering just prior to the Company's IPO. In connection with this termination, HealthStream gave WebMD the right to sell the shares back to HealthStream at any time through March 30, 2001. On February 8, 2001, WebMD exercised its right to sell the 1.1 million shares of HealthStream common stock back to the Company at $1.7833 per share. The Company reacquired the shares on February 16, 2001. In connection with the termination of the prior WebMD agreement, HealthStream recognized a gain of $1.5 million representing the reversal of the scheduled $1.5 million fixed payment, which was accrued during the quarter ended September 30, 2000. To date, we have incurred substantial costs to develop our technologies, create, license and acquire our content, build brand awareness, develop our infrastructure and expand our business, and have yet to achieve significant revenues. As a result, we have incurred operating losses in each fiscal quarter since 1994. We expect operating losses and negative cash flow to continue for the foreseeable future as we plan to increase our operating expenses to help expand our business. These costs could have a material adverse effect on our future financial condition or operating results. We believe that period-to-period comparisons of our financial results are not necessarily meaningful, and should not be relied upon as an indication of our future performance. 13
16 RESULTS OF OPERATIONS REVENUES AND EXPENSE COMPONENTS The following descriptions of the components of revenues and expenses apply to the comparison of results of operations. Revenues. Revenues consist of the provision of services through our ASP-based products, the licensing of the Company's installed learning management systems, maintenance and support services, content subscriptions, content and courseware development, Web cast events, event development and registration services, sponsorship services, Web site development, professional and technical consulting services, online products, sale of CD-ROMs and training services. Cost of Revenues. Cost of revenues consists primarily of salaries and employee benefits, materials, and depreciation associated with event development and registration services, ASP-based products, and development of interactive media projects as well as royalties paid to content providers and distribution partners based on a percentage of revenues. Product Development. Product development expenses consist primarily of salaries and employee benefits, depreciation, third-party content acquisition costs, costs associated with the development of content and expenditures associated with maintaining and operating our Web sites and training delivery and administration platforms. Office Consolidation Charge. The Company recorded a non recurring office consolidation charge as a result of closure of its Dallas and Boston offices. The charge consisted of lease obligations and impairment of certain fixed assets. Selling, General and Administrative. General and administrative expenses consist primarily of salaries and employee benefits, facility costs, depreciation, amortization of intangibles, fees for professional services and royalties paid to content providers that are of a fixed nature. Sales and marketing expenses consist primarily of salaries and employee benefits, bonuses, advertising, promotions and related marketing costs. Other Income/Expense. The primary component of other expense is interest expense related to debt, loans from related parties and capital leases. The primary component of other income is interest income related to interest earned on cash, cash equivalents and investments. THREE MONTHS ENDED JUNE 30, 2000 COMPARED TO THREE MONTHS ENDED JUNE 30, 2001 Revenues. Revenues increased $1.3 million, from $2.2 million in 2000 to $3.5 million in 2001, due to revenues attributable to acquired businesses and organic growth. Of the increase, $1.0 million is attributable to event development and registration services associated with the EDI acquisition, while the remaining increase related to organic growth associated with our ASP-based products and Web cast events. During the second quarter of 2000, approximately 60% of revenues related to services to healthcare organizations and 40% related to services to pharmaceutical and medical device companies, including revenues from the Web distribution network. During 2001, revenues were split almost evenly between services to healthcare organizations and services to pharmaceutical and medical device companies, including revenues from the Web distribution network. Cost of Revenues. Cost of revenues increased $0.1 million, from $1.0 million in 2000 to $1.1 million in 2001. While cost of revenues did not significantly increase, the components changed from 2000 to 2001. During the first half of 2001, cost of revenues included costs associated with event development and registration services and related personnel, Web cast event personnel, ASP implementation and other personnel. During 2000, cost of revenues included more development, installation and training personnel. Cost of revenues, as a percentage of revenues, decreased from approximately 47% in 2000 to approximately 32% in 2001, primarily as a result of increased revenues related to our ASP-based products and services. 14
17 Product Development. Product development expenses increased $0.1 million, from $1.2 million in 2000 to $1.3 million in 2001. The slight increase in product development expenses related to increased personnel costs. Product development as a percentage of revenues decreased from approximately 56% in 2000 to 36% in 2001 as a result of increased growth in revenues from ASP-based products and reduced development focus on our client server products. Office Consolidation Charge. During the quarter ended June 30, 2001, the Company recorded a non recurring office consolidation charge of $0.4 million as a result of closure of its Dallas and Boston offices. The charge consisted of lease obligations of approximately $0.2 million and impairment of certain fixed assets of approximately $0.2 million. Selling, General and Administrative. Selling, general and administrative expenses increased $0.4 million, from $5.9 million in 2000 to $6.3 million in 2001. General and administrative expenses decreased from $2.9 million in 2000 to $2.3 million in 2001. Sales and marketing expenses, including personnel costs, increased $0.1 million, from $1.5 million in 2000 and $1.6 million in 2001. Depreciation and amortization expenses increased $0.9 million from approximately $1.5 million in 2000 to $2.4 million in 2001. As a percentage of revenues, selling, general and administrative expenses decreased from approximately 269% in 2000 to approximately 179% in 2001. General and administrative expenses decreased by $0.6 million due to a decline in royalties to WebMD. As a result of the renegotiation of the WebMD agreement during the first quarter of 2001, $1.5 million of royalties paid during the second quarter of 2000 were not repeated in 2001. This decrease in royalties was offset by increases in personnel and related facilities and travel associated with the acquisitions that occurred during the second half of 2000. Sales and marketing expenses were comparable between 2000 and 2001, however the components of this spending changed. During 2000, the Company incurred expenses for direct marketing campaigns and brand advertising campaigns. During 2001, the Company's sales and marketing spending were primarily related to sales and marketing personnel and relationship specific campaigns. Depreciation and amortization increased by $0.9 million due to the amortization of intangibles including goodwill, non-competition agreements and customer lists related to the acquisitions noted above. In addition, depreciation increased as a result of acquired fixed assets and additions related to additional personnel. Other Income/Expense. Other income and expense decreased $0.1 million, from approximately $0.5 million in 2000 to $0.4 million in 2001 due to decreased interest income, which resulted from lower cash and investment balances in 2001 when compared to 2000. Net Loss. Net loss decreased $0.4 million from $5.6 million in 2000 to $5.2 million in 2001 due to the factors described above. SIX MONTHS ENDED JUNE 30, 2000 COMPARED TO SIX MONTHS ENDED JUNE 30, 2001 Revenues. Revenues increased $3.0 million, from $3.6 million in 2000 to $6.6 million in 2001, due to revenues attributable to acquired businesses and organic growth. Of the increase, approximately $1.7 million related to the event development and registration business acquired in July 2000 from EDI, while the remaining net increase is primarily attributable to increased organic revenues from both our ASP-based products and Web cast events. During the first half of 2000, approximately 55% of revenues related to services to healthcare organizations and 45% related to services to pharmaceutical and medical device companies, including revenues from the Web distribution network. Revenues for 2001 were split almost evenly between services to healthcare organizations and services to pharmaceutical and medical device companies, including revenues from the Web distribution network. 15
18 Cost of Revenues. Cost of revenues increased $0.8 million, from $1.8 million in 2000 to $2.6 million in 2001. Of the increase, $0.6 million is primarily attributable to personnel costs associated with event development and registration services. The remainder of the increase is associated with additional personnel associated with our ASP-based products and services. Cost of revenues, as a percentage of revenues, decreased from approximately 49% in 2000 to 40% in 2001, primarily as a result of increased revenues related to our ASP-based products and services. Product Development. Product development expenses increased $0.1 million, from $2.4 million in 2000 to $2.5 million in 2001. The slight increase in product development expenses related to increased personnel costs. Product development as a percentage of revenues decreased from approximately 67% in 2000 to 38% in 2001 as a result of increased growth in revenues from ASP-based products and reduced development focus on our client server products. Office Consolidation Charge. During the six months ended June 30, 2001, the Company recorded a non recurring office consolidation charge of $0.4 million as a result of closure of its Dallas and Boston offices. The charge consisted of lease obligations of approximately $0.2 million and impairment of certain fixed assets of approximately $0.2 million. Selling, General and Administrative. Selling, general and administrative expenses increased $2.5 million, from $9.1 million in 2000 to $11.6 million in 2001. General and administrative expenses were $3.9 million in both 2000 and 2001. Sales and marketing expenses, including personnel costs, increased from $2.6 million in 2000 to $2.9 million in 2001. Depreciation and amortization expenses increased from $2.6 million in 2000 to $4.8 million in 2001. As a percentage of revenues, selling, general and administrative expenses decreased from approximately 250% in 2000 to 177% in 2001. General and administrative expenses were comparable between years, however the components of this category changed. When compared to 2000, content and royalty expenses declined approximately $0.9 million as a result of the renegotiation of the WebMD agreement during the first quarter of 2001. This decrease was offset by increases in personnel and facility costs related to the EDI and SynQuest acquisitions and increases in severance expenses related to consolidation of duplicative functions. Sales and marketing expenses increased $0.3 million to $2.9 million primarily as a result of sales personnel added in connection with the SynQuest acquisition. This increase was partially offset by a decline in spending on direct marketing and advertising campaigns. Depreciation and amortization increased by $2.2 million due to increases in amortization and depreciation associated with the 2000 and 2001 acquisitions. Other Income/Expense. Other income and expense increased $0.4 million, from approximately $0.6 million in 2000 to $1.0 million in 2001 related to increased interest income which resulted from the investment of the proceeds of the Company's IPO during the second quarter of 2000. This increase in interest income was offset by a loss of approximately $100,000 related to the write off of an investment. In addition, interest expense decreased approximately $100,000 related to the conversion of related party notes and repayment of debt in connection with the Company's IPO. Net Loss. Net loss increased $0.5 million from $9.1 million in 2000 to $9.6 million in 2001 due to the factors described above. LIQUIDITY AND CAPITAL RESOURCES Since our inception, we have financed our operations largely through the public and private placements of equity securities, loans from related parties and, to a lesser extent, from revenues generated from custom development fees and product sales. In April 2000 we completed an initial public offering of common stock resulting in net proceeds of $42.2 million and a concurrent private placement of common stock to WebMD resulting in net proceeds of $10.0 million. 16
19 Net cash used in operating activities was $7.8 million in the first six months of 2000 and $7.3 million in the first six months of 2001. Cash used in operating activities during the six months ended June 30, 2000, which excludes the effects of acquisitions, was attributable to a $9.1 million net operating loss and increases in accounts and unbilled receivables, prepaid and other current assets, and decreases in deferred revenue which were partially offset by increases in depreciation, amortization and non cash warrant amortization, as well as increases in accounts payable and accrued liabilities. Cash used in operating activities during the six months ended June 30, 2001 related to the $9.6 million net loss, the non-cash gain on the WebMD renegotiation, increases in accounts and unbilled receivables, prepaid development, prepaid expenses and other current assets, other assets, decreases in accrued liabilities, registration liabilities and deferred revenue. These operating uses of cash were offset by non cash warrant expense, the office consolidation charge, increases in depreciation and amortization as well as a decline in restricted cash. Net cash used in investing activities was $2.7 million in the first six months of 2000 and $1.2 million in the first six months of 2001. Cash used in investing activities during the first six months of 2000 related primarily to the m3 and EMINet acquisitions totaled $1.5 million and cash paid for the purchase of property and equipment totaled $1.3 million. In the first six months of 2000, these outflows were partially offset by the receipt of $0.1 million from the sale of investments by the Company. During the first six months of 2001, cash outflows related to $0.3 million for the purchase of de'MEDICI Systems, $0.2 million from the issuance of a note receivable and the $0.6 million for the purchase of property and equipment. Cash provided by financing activities was $51.1 million in the first six months of 2000 while $2.1 million was used in financing activities in the first six months of 2001. During the first six months of 2000, cash provided by financing activities related to $54.2 million received from the sale of common stock and $0.4 million received in connection with the exercise of stock options, which was partially offset by $2.0 million of expenses related to the common stock offering and $1.4 million of repayments of debt and capital leases. Cash used in financing activities during the first six months of 2001 related primarily to $2.0 million related to the repurchase of common stock from WebMD. In connection with our agreement with HCA, HCA is paying us revenues of at least $12.0 million over the four-year term of the agreement. As discussed above, the Company expects to amortize the estimated fair value of the warrant ($8.8 million) as a reduction of revenues proportionately over the term of this agreement. This amortization will fluctuate based on the revenues received from this agreement and will vary as a percentage of revenues based on the estimated revenues over the course of the agreement. We also expect to incur additional product development costs, some of which will be capitalized, and sales and marketing costs to grow our business. As a result of the anticipated growth in personnel, development and online transactions, we expect that our capital expenditures will be approximately $2.0 million during the remainder of 2001. Our arrangements with content, development and distribution partners have typically provided for payments based on revenues, and we expect to continue similar arrangements in the future. In addition to such percentage payments, we have fixed payment commitments of approximately $200,000 during the remainder of 2001. We also have fixed educational grant commitments of approximately $70,000 during the remainder of 2001 and approximately $70,000 during 2002. We have variable commitments of approximately $250,000 related to agreements under which other organizations have agreed to provide content development services for us. Payments under these development arrangements are contingent upon the delivery of services. As of June 30, 2001, our primary source of liquidity was $31.2 million of cash and cash equivalents, restricted cash, investments and related interest receivable. As of July 31, 2001, the Company had cash, restricted cash, investments and related interest receivable of $30.1 million. We believe that our existing cash, restricted cash, investments and interest receivable will be sufficient to meet anticipated cash needs for working capital, capital expenditures and acquisitions for at least the next 12 months. Our growth strategy may include acquiring companies that complement our products and services. We anticipate that these acquisitions, if any, will be effected through a combination of issuance of our common stock and cash payments. Failure to generate sufficient cash flow from operations, failure to raise additional capital when required in sufficient amounts and on acceptable terms or our inability to use our common stock to finance acquisitions could harm our business, results of operations and financial condition. 17
20 RECENT ACCOUNTING PRONOUNCEMENTS In June 2001, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 141, Business Combinations, and No. 142, Goodwill and Other Intangible Assets, effective for fiscal years beginning after December 15, 2001. Under the new rules, goodwill and intangible assets deemed to have indefinite lives will no longer be amortized but will be subject to annual impairment tests in accordance with the Statements. Other intangible assets will continue to be amortized over their useful lives. The Company will apply the new rules on accounting for goodwill and other intangible assets beginning in the first quarter of 2002. While the Company has not completed its assessment of the impact of these Statements, application of the non amortization provisions of the Statement would result in an decrease in net loss of approximately $7.5 million, ($0.38 per share) per year. This estimate is based on the Company's current level of amortization expense for all intangibles and the current weighted average shares outstanding. During 2002, the Company will perform the first of the required impairment tests of goodwill and indefinite lived intangible assets as of January 1, 2002. The Company has not yet determined what the effect of these tests will be on the earnings and financial position of the Company. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK We are exposed to market risk from changes in interest rates. We do not have any foreign currency exchange rate risk or commodity price risk. As of June 30, 2001, we had no outstanding indebtedness other than capital lease arrangements. Accordingly, the Company is not exposed to significant market risk. The Company is exposed to market risk with respect to the cash and cash equivalents that it invests. At July 31, 2001, we had approximately $30.1 million of cash, restricted cash, investments and accrued interest that were invested in a combination of short and long-term investments. At this investment level, a hypothetical 10% decrease in the interest rate would decrease interest income and increase net loss on an annualized basis by approximately $301,000. The Company manages its investment risk by investing in corporate debt securities, foreign corporate debt and secured corporate debt securities with minimum acceptable credit ratings. For certificates of deposit and corporate obligations, ratings must be A2/A or better; A1/P1 or better for commercial paper; A2/A or better for taxable or tax advantaged auction rate securities and AAA or better for tax free auction rate securities. The Company also requires that all securities must mature within 24 months from the original settlement date, the average portfolio shall not exceed 18 months, and the greater of 10% or $5.0 million shall mature within 90 days. Further, the Company's investment policy also limits concentration exposure and other potential risk areas. The above market risk discussion and the estimated amounts presented are forward-looking statements of market risk assuming the occurrence of certain adverse market conditions. Actual results in the future may differ materially from those projected as a result of actual developments in the market. 18
21 PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS. On November 17, 2000, a complaint was filed by Challenger Corporation in the Circuit Court of Tennessee for the Thirtieth Judicial District at Memphis against HealthStream, SynQuest Technologies, Inc. and two individual shareholders of SynQuest Technologies. The complaint asserts that HealthStream violated the terms of a licensing agreement entered into between HealthStream and the plaintiff and that HealthStream allegedly failed to pay royalties due to the plaintiff pursuant to the terms of that agreement. The plaintiff also alleges that HealthStream induced SynQuest Technologies to breach a marketing agreement allegedly entered into between SynQuest and the plaintiff. Alternatively, the plaintiff alleges that HealthStream, which purchased certain assets of SynQuest, is liable for SynQuest's alleged breach of the marketing agreement pursuant to the legal theory of successor liability. The aggregate damages alleged total approximately $9.0 million. We believe the allegations in the complaint are without merit, intend to defend the litigation vigorously and do not believe this litigation will have a material adverse effect on our financial condition or results of operations. ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS. None ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. On May 31, 2001, the Company held its Annual Meeting of Shareholders. At the Annual Meeting, the shareholders of the Company elected the following persons to serve as Class I directors to serve until the Annual Meeting of Shareholders in 2004 and until such time as their respective successors are duly elected and qualified with the number of votes cast for, against or withheld as set forth opposite their names: <TABLE> <CAPTION> Votes ----------------------------- Withheld Nominee For Authority - --------------------------- ---------- ---------- <S> <C> <C> Thompson Dent 14,058,207 420,536 James Daniell 14,389,937 88,806 William Stead 14,389,997 88,746 </TABLE> The shareholders of the Company elected the following person to serve as a Class II director to serve until the Annual Meeting of Shareholders in 2002 and until such time as her respective successor is duly elected and qualified with the number of votes cast for, against or withheld as set forth opposite her name: <TABLE> <CAPTION> Votes ----------------------------- Withheld Nominee For Authority - --------------------------- ---------- ---------- <S> <C> <C> Linda Rebrovick 14,389,997 88,746 </TABLE> 19
22 The shareholders of the Company ratified that Ernst & Young LLP will audit the Company's consolidated financial statements for 2001 with the following number of votes cast for, against or abstaining: <TABLE> <CAPTION> Votes --------------------------------------- For Against Abstain ---------- ------- ------- <S> <C> <C> <C> 14,473,122 4,425 1,196 </TABLE> ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K. (a) Exhibits None (b) Reports on Form 8-K None 20
23 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. HEALTHSTREAM, INC. By: /s/ ARTHUR E. NEWMAN ---------------------------------------- Arthur E. Newman Chief Financial Officer August 13, 2001 21